Copy
View this email in your browser

Nov.27/23

🍁 Belzutifan Video Examples

I can’t travel to the VHL Alliance’s Family Weekend in California, but thankfully the presentations are recorded! As a patient, the ones I’ve seen so far are interesting! Below are 2 “practical/real-life” excerpts.

(We will also have a “movie night” with our online chat group this week. We can watch these videos simultaneously. Click a link and join everyone watching the same video at the same time)

 

“Belzutifan in VHL” 28:13 to 34:30 6 minutes

  • Implications for clinical practice
  • How do we decide which patient should receive Belzutifan? Intro and Principles
  • Case scenario #1
  • Case scenario #2

from Systemic Therapy for Von Hippel-Lindau Associated Tumors | Ramaprasad Srinivasan, MD, PhD. VHL Alliance Family Weekend, Stanford Medical Center: Palo Alto, California, USA, October 2022

 

“FAQs asked by patients about Welireg" 13:18 to 17:03 (4 minutes)*

  • When should it be started?
  • Should it be used preemptively?
  • Should it be used before or after surgery or radiation?
  • Will resistance develop?


*based on my early experience-Lawrence Recht, MD, New Perspectives in the Treatment of CNS VHL

_____________

 

“Family Weekend 2022,” Stanford Medical Centre, Complete Presentation List

 

VHL Alliance YouTube Channel
 

 

Donate
Help us to fill a gap in Canada.
We have moderate expenses to operate a peer support network specifically for VHL patients and their families in Canada.


VHL Canada
Registered Charity BN: 800804676RR0001

Our temporary mailing address is:
VHL Canada
C/O: H. Seo
618 Gladstone Avenue
Toronto ON, M6J 3H4

 

Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.

 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
VHL Canada · 2938 Dundas Street West, PO Box 70510 · Toronto, On M6P 4E7 · Canada

Email Marketing Powered by Mailchimp